Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $145.58 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HARMONY BIOSCIENCES LLC | $61.06 | 3 | $0 (2024) |
| Novo Nordisk Inc | $18.89 | 1 | $0 (2023) |
| Renalytix AI, Inc. | $18.09 | 1 | $0 (2023) |
| Avadel CNS Pharmaceuticals, LLC | $17.04 | 1 | $0 (2023) |
| AbbVie Inc. | $15.57 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $14.93 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61.06 | 3 | HARMONY BIOSCIENCES LLC ($61.06) |
| 2023 | $84.52 | 5 | Novo Nordisk Inc ($18.89) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.80 | General |
| Category: Narcoplepsy | ||||||
| 06/24/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $25.62 | General |
| Category: Narcoplepsy | ||||||
| 01/23/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| Category: Narcoplepsy | ||||||
| 12/13/2023 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/30/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2023 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 09/11/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.89 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 35 | 35 | $7,798 | $2,523 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 22 | $3,902 | $1,354 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $3,895 | $1,169 | 30.0% |
About Dr. Michael William, MD
Dr. Michael William, MD is a Sleep Medicine healthcare provider based in Frisco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2019. The National Provider Identifier (NPI) number assigned to this provider is 1669931440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael William, MD has received a total of $145.58 in payments from pharmaceutical and medical device companies, with $61.06 received in 2024. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($145.58).
As a Medicare-enrolled provider, William has provided services to 35 Medicare beneficiaries, totaling 35 services with total Medicare billing of $2,523. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Sleep Medicine
- Location Frisco, TX
- Active Since 03/19/2019
- Last Updated 04/15/2024
- Taxonomy Code 207RS0012X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669931440
Products in Payments
- WAKIX (Drug) $61.06
- KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) $18.09
- LUMRYZ (Drug) $17.04
- UBRELVY (Drug) $15.57
- AREXVY (Drug) $14.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.